Showing 8001-8010 of 23108 results for "".
Decoding Disability Worsening in MS: The Case for Combining CSF and Serum Biomarkers
https://reachmd.com/programs/neurofrontiers/decoding-disability-worsening-in-ms-the-case-for-combining-csf-and-serum-biomarkers/32824/A new multicenter study highlights how serum and CSF biomarkers can refine prognostic accuracy and guide treatment strategies in multiple sclerosis (MS). ReachMD's Ryan Quigley explains key findings and provides insights on how integrating these biomarkers at diagnosis could move MS care toward moreOne Year or Two? DANTE Trial Explores Immunotherapy Duration in Metastatic Melanoma
https://reachmd.com/programs/project-oncology/one-year-or-two-dante-trial-explores-immunotherapy-duration-in-metastatic-melanoma/33002/The DANTE phase III trial investigated if stopping anti–PD-1 therapy at one year yields comparable outcomes to longer treatment in metastatic melanoma. Read more about the findings and their potential clinical implications.Practical Dermatology Roundtable: Generalized Pustular Psoriasis, Ch. 2
https://reachmd.com/programs/the-practical-dermatology-roundtable/practical-dermatology-roundtable-generalized-pustular-psoriasis-ch-2/32758/Host Neal Bhatia, MD, FAAD, and guests Laura K. Ferris, MD, PhD, FAAD, and Jason E. Hawkes, MD, MS, FAAD, discuss the differences between psoriasis subtypes, the importance of a specialized therapeutic approach targeting the IL-36 pathway for generalized pustular psoriasis, and the role of neutrophiStrategies and Considerations for Managing MS in Pregnant Women
https://reachmd.com/programs/frontlines-multiple-sclerosis/strategies-and-considerations-for-managing-ms-in-pregnant-women/32667/Multiple sclerosis treatment for pregnant women can come with unique considerations. Hear expert insights on addressing them to optimize care.Recap of Maui Derm Hawaii Meeting
https://practicaldermatology.com/series/dermwire-tv/recap-of-maui-derm-hawaii-meeting/32717/In this week's DermwireTV, key stakeholders in dermatology gather in Hawaii to discuss the latest developments and advances; a new review examines whether IgE-targeting therapies could represent a new treatment avenue for psoriasis and atherosclerosis; and the founder of SEEN hair care joTreating BPSD with Cannabinoids: What We Currently Know
https://reachmd.com/programs/neurofrontiers/treating-bpsd-with-cannabinoids-what-we-currently-know/15451/Explore key findings from clinical trials about the use of cannabinoids to treat behavioral and psychological symptoms of dementia.Managing Patients with Lower Gastrointestinal Bleeding
https://reachmd.com/programs/gi-insights/managing-patients-with-lower-gastrointestinal-bleeding/15109/What are the updated guidelines from the American College of Gastroenterology? Join in on the discussion.Exploring Precision Medicine in the Treatment of Diabetes
https://reachmd.com/programs/diabetes-discourse/exploring-precision-medicine-in-the-treatment-of-diabetes/14210/What would precision medicine in treating diabetes look like when applied to clinical practice? Find out more.Key COVID-19 Considerations: Highlights from Poster Sessions at IDWeek
https://reachmd.com/programs/idsa-action-center/key-covid-19-considerations-highlights-from-poster-sessions-at-idweek/14526/As IDWeek 2022 kicks off, let’s take a look at some of the posters focused on COVID-19 presented at this year’s meeting.Polio Detected in the U.S.: What Do We Need to Know?
https://reachmd.com/programs/clinicians-roundtable/polio-detected-in-the-us-what-do-we-need-to-know/13940/A case of polio was recently reported in the U.S. What do we need to know about this potential spread?